Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 150

Similar articles for PubMed (Select 16612590)

1.

A new model of insulin-deficient diabetes: male NOD mice with a single copy of Ins1 and no Ins2.

Babaya N, Nakayama M, Moriyama H, Gianani R, Still T, Miao D, Yu L, Hutton JC, Eisenbarth GS.

Diabetologia. 2006 Jun;49(6):1222-8. Epub 2006 Apr 13.

PMID:
16612590
2.

Compensatory responses in mice carrying a null mutation for Ins1 or Ins2.

Leroux L, Desbois P, Lamotte L, Duvillié B, Cordonnier N, Jackerott M, Jami J, Bucchini D, Joshi RL.

Diabetes. 2001 Feb;50 Suppl 1:S150-3.

3.

Proinsulin 2 knockout NOD mice: a model for genetic variation of insulin gene expression in type 1 diabetes.

Dubois-Lafforgue D, Mogenet L, Thébault K, Jami J, Krief P, Boitard C.

Diabetes. 2002 Dec;51 Suppl 3:S489-93.

4.

Ins1 gene up-regulated in a beta-cell line derived from Ins2 knockout mice.

Leroux L, Durel B, Autier V, Deltour L, Bucchini D, Jami J, Joshi RL.

Int J Exp Diabesity Res. 2003 Jan-Mar;4(1):7-12.

5.

Transgenic expression of human INS gene in Ins1/Ins2 double knockout mice leads to insulin underproduction and diabetes in some male mice.

Karaca M, Durel B, Languille L, Lamotte L, Tourrel-Cuzin C, Leroux L, Abou Sleymane G, Saint-Just S, Bucchini D, Ktorza A, Joshi RL.

Front Biosci. 2007 Jan 1;12:1586-93.

PMID:
17127405
6.

Increased islet cell proliferation, decreased apoptosis, and greater vascularization leading to beta-cell hyperplasia in mutant mice lacking insulin.

Duvillié B, Currie C, Chrones T, Bucchini D, Jami J, Joshi RL, Hill DJ.

Endocrinology. 2002 Apr;143(4):1530-7.

PMID:
11897712
7.

In vivo cytotoxicity of insulin-specific CD8+ T-cells in HLA-A*0201 transgenic NOD mice.

Jarchum I, Baker JC, Yamada T, Takaki T, Marron MP, Serreze DV, DiLorenzo TP.

Diabetes. 2007 Oct;56(10):2551-60. Epub 2007 Jul 9.

8.

Dominant-negative effects of a novel mutated Ins2 allele causes early-onset diabetes and severe beta-cell loss in Munich Ins2C95S mutant mice.

Herbach N, Rathkolb B, Kemter E, Pichl L, Klaften M, de Angelis MH, Halban PA, Wolf E, Aigner B, Wanke R.

Diabetes. 2007 May;56(5):1268-76. Epub 2007 Feb 15.

9.
10.

The Ins2Akita mouse as a model of early retinal complications in diabetes.

Barber AJ, Antonetti DA, Kern TS, Reiter CE, Soans RS, Krady JK, Levison SW, Gardner TW, Bronson SK.

Invest Ophthalmol Vis Sci. 2005 Jun;46(6):2210-8.

PMID:
15914643
11.

The natural history of insulin content in the pancreas of female and male non-obese diabetic mouse: implications for trials of diabetes prevention in humans.

Valorani MG, Hawa MI, Buckley LR, Afeltra A, Cacciapaglia F, Pozzilli P.

Diabetes Metab Res Rev. 2004 Sep-Oct;20(5):394-8.

PMID:
15343585
12.

Long-term prevention of diabetes and marked suppression of insulin autoantibodies and insulitis in mice lacking native insulin B9-23 sequence.

Nakayama M, Babaya N, Miao D, Gianani R, Liu E, Elliott JF, Eisenbarth GS.

Ann N Y Acad Sci. 2006 Oct;1079:122-9.

PMID:
17130542
13.

E2F-1-deficient NOD/SCID mice developed showing decreased saliva production.

Matsui-Inohara H, Uematsu H, Narita T, Satoh K, Yonezawa H, Kuroda K, Ito T, Yoneda S, Kawarai T, Sugiya H, Watanabe H, Senpuku H.

Exp Biol Med (Maywood). 2009 Dec;234(12):1525-36. doi: 10.3181/0905-RM-173.

PMID:
19934373
14.

Survival of an islet allograft deficient in iNOS after implantation into diabetic NOD mice.

Börjesson A, Andersson AK, Sandler S.

Cell Transplant. 2006;15(8-9):769-75.

PMID:
17269447
15.

Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.

Hong EG, Jung DY, Ko HJ, Zhang Z, Ma Z, Jun JY, Kim JH, Sumner AD, Vary TC, Gardner TW, Bronson SK, Kim JK.

Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1687-96. Epub 2007 Oct 2.

16.

Insulin2 gene (Ins2) transcription by NOD bone marrow-derived cells does not influence autoimmune diabetes development in NOD-Ins2 knockout mice.

Martin-Pagola A, Pileggi A, Zahr E, Vendrame F, Damaris Molano R, Snowhite I, Ricordi C, Eisenbarth GS, Nakayama M, Pugliese A.

Scand J Immunol. 2009 Nov;70(5):439-46. doi: 10.1111/j.1365-3083.2009.02316.x.

PMID:
19874548
17.

Phenotypic alterations in insulin-deficient mutant mice.

Duvillié B, Cordonnier N, Deltour L, Dandoy-Dron F, Itier JM, Monthioux E, Jami J, Joshi RL, Bucchini D.

Proc Natl Acad Sci U S A. 1997 May 13;94(10):5137-40.

18.

Expression of transgene encoded TGF-beta in islets prevents autoimmune diabetes in NOD mice by a local mechanism.

Grewal IS, Grewal KD, Wong FS, Wang H, Picarella DE, Janeway CA Jr, Flavell RA.

J Autoimmun. 2002 Aug-Sep;19(1-2):9-22.

PMID:
12367555
19.

Thymic expression of mutated B16:A preproinsulin messenger RNA does not reverse acceleration of NOD diabetes associated with insulin 2 (thymic expressed insulin) knockout.

Nakayama M, Babaya N, Miao D, Sikora K, Elliott JF, Eisenbarth GS.

J Autoimmun. 2005 Nov;25(3):193-8. Epub 2005 Nov 14.

PMID:
16289958
20.

Insulin transactivator MafA regulates intrathymic expression of insulin and affects susceptibility to type 1 diabetes.

Noso S, Kataoka K, Kawabata Y, Babaya N, Hiromine Y, Yamaji K, Fujisawa T, Aramata S, Kudo T, Takahashi S, Ikegami H.

Diabetes. 2010 Oct;59(10):2579-87. doi: 10.2337/db10-0476. Epub 2010 Aug 3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk